An approach to the patient with a post-nasal drip and rhinosinusitis by Lubbe, D E
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ojfp20
Download by: [University of Cape Town Libraries] Date: 12 January 2016, At: 02:59
South African Family Practice
ISSN: 2078-6190 (Print) 2078-6204 (Online) Journal homepage: http://www.tandfonline.com/loi/ojfp20
An approach to the patient with a post-nasal drip
and rhinosinusitis
DE Lubbe MBChB, FCORL(SA)
To cite this article: DE Lubbe MBChB, FCORL(SA) (2009) An approach to the patient with
a post-nasal drip and rhinosinusitis, South African Family Practice, 51:5, 376-380, DOI:
10.1080/20786204.2009.10873886
To link to this article:  http://dx.doi.org/10.1080/20786204.2009.10873886
© 2009 SAAFP. Published by Medpharm.
Published online: 15 Aug 2014.
Submit your article to this journal 
Article views: 29
View related articles 
CPD Article: An approach to the patient with a post-nasal drip and rhinosinusitis
376 Vol 51 No 5SA Fam Pract 2009
Abstract  SA Fam Pract 2009;51(5):376-380
Post-nasal drip (PND) can be a bothersome symptom and one of the main reasons for patients visiting a general practitioner (GP), pulmonologist or 
ear, nose and throat (ENT) surgeon. It can be either a symptom, sometimes not appreciated by the examining practitioner, or an important clinical 
sign suggesting rhinosinusitis. This article aims to explain the aetiological factors and initial work-up of the patient with a PND and rhinosinusitis and 
suggest a treatment paradigm for practitioners. 
  Peer reviewed. (Submitted:2009-05-03, Accepted:2009-06-16). Available online at www.safpj.co.za. © SAAFP  
Introduction
Approximately one litre of mucus is produced by the nasal mucosa 
and tracheobronchial tree every day. Normal mucociliary function 
ensures that mucus produced by the paranasal sinuses and nasal 
cavity is transported into the nasopharynx and is eventually swallowed. 
For patients to become aware of a post-nasal drip (PND), the mucus 
characteristics need to be altered. Excess mucus production, a change 
in mucus viscosity or infected mucus will make the patient aware of 
the presence of a PND or ‘phlegm in the throat’. It is important to have 
a structured approach to the patient presenting with a PND, to correctly 
treat the underlying or associated condition and to avoid unnecessary 
investigations and/or surgery. 
Chronic cough and nasal disease
Patients suffering from a chronic cough often first present to a 
pulmonologist. A chronic cough is defined as one that persists for more 
than eight weeks. Ninety per cent of patients with chronic cough suffer 
from either laryngopharyngeal reflux (LPR), bronchial asthma or post-
nasal drip syndrome (PNDS), and these conditions need a systematic 
approach.1 It is important to first rule out angiotensin-converting 
enzyme (ACE)-inhibitors and post-infectious causes before requesting 
unnecessary investigations and prescribing medication. The term PNDS 
is non-specific and should rather be replaced with rhinosinusitis if a 
purulent nasal drip is found to be present.2 Rhinosinusitis is a condition 
that can be clinically diagnosed by using a group of symptoms. It does 
not require special investigations such as computed tomography or 
endoscopy. Medication should be directed at the cause of the PND rather 
than treating the symptom itself. It has been shown that rhinosinusitis 
with PND is frequently over-diagnosed as being the underlying cause for 
a chronic cough. In a recent study it was demonstrated that only a small 
proportion of patients with purulent rhinosinusitis with no co-morbid 
lung pathology suffer from chronic cough.2
Approach to the patient with a post-nasal drip
When considering causative factors, the following diagnosis should be 
considered: allergic, infectious and non-allergic non-infective rhinitis. 
The differential diagnosis should include nasal polyps, mechanical 
obstruction, tumours, granulomatous conditions and cerebrospinal fluid 
leaks (Table I).
1. Does the patient suffer from allergic rhinitis?
It is important to determine whether the patient has any symptoms 
suggesting rhinitis and, if present, whether this is allergic or non-allergic 
in nature. Rhinitis is present when the patient has two or more of the 
following symptoms: blockage, rhinorrhoea, itchiness and sneezing. 
Allergic rhinitis is diagnosed when these symptoms are due to an 
immunoglobulin E (IgE)-mediated inflammatory response secondary to 
allergen exposure. Patients with persistent (perennial) allergic rhinitis 
can have chronic inflammatory changes that can be misdiagnosed as 
chronic rhinosinusitis (CRS). It is therefore essential to correctly identify 
these patients to avoid unnecessary sinus surgery. When allergic rhinitis 
is strongly suspected based on a positive family history of atopy and the 
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Table I: Classification of rhinosinusitis
1. Allergic Intermittent (seasonal)
Persistent (perennial)
2.  Infectious Acute
Chronic
3.  Other Occupational
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abovementioned symptom complex, empiric therapy should be instituted 
and directed at the main symptom (Table II). 
The mainstay of treatment for allergic rhinitis remains topical 
corticosteroids and oral antihistamines. Fluticazone and mometasone 
have the lowest bioavailability of all the topical corticosteroids, but 
there is no difference in the efficacy when compared to the other topical 
corticosteroids.3 Ipratropium bromide is an atropine-like nasal spray 
that can be used in patients with watery rhinorrhoea where topical 
corticosteroids are not effective. Allergen avoidance is important and 
immunotherapy is an option for selected patients with severe symptoms 
who fail treatment with the above measures. Immunotherapy is 
especially effective in patients with seasonal allergies who are allergic 
to a few allergens only. Those patients not responding to therapy should 
be further investigated for atopy by either doing skin-prick testing or 
specific CAP RAST testing. Skin-prick tests are quick and inexpensive, 
but cannot be performed on patients on antihistamines, or who suffer 
from severe eczema, dermagraphism or previous anaphylaxis. 
2. Does the patient suffer from non-allergic rhinitis?
Non-allergic rhinitis is present if the patient suffers from two or more of 
the abovementioned symptoms but without an allergic aetiology. Studies 
show that patients are likely to have nasal disease if they suffer from 
more than five sneezes or nose blowing episodes a day.4 A recent study 
in the United States of America showed that 34% of patients with rhinitis 
have a combination of allergic and non-allergic rhinitis.5 Rhinorrhoea 
can be present with or without the presence of a constant PND. The 
following aetiologies must be excluded when a patient complains of 
nasal symptoms:
•	 Viral rhinitis or common cold – this is mostly self-limiting but can 
occasionally lead to chronic rhinosinusitis, especially if the patient 
has underlying anatomical abnormalities.
•	 Idiopathic or vasomotor rhinitis – triggered by irritants and 
changes in atmospheric conditions.
•	 Occupational rhinitis – triggered by irritant or toxic compounds at 
the workplace (aldehydes, aircraft fuel, solvents).
•	 Hormonal rhinitis – pregnancy rhinitis due to oestrogens causing 
vascular engorgement in the nasal cavity.
•	 Drug-induced rhinitis – aspirin and other non-steroidal anti-
inflammatory drugs (NSAIDs), beta-blockers, ACE-inhibitors, oral 
contraceptives, oxymetazoline in nasal decongestants (rebound 
rhinitis or rhinitis medicamentosa).
•	 Other – food-induced, emotional-induced, chemical-induced, 
smoking.
Treatment is aimed at avoidance of the irritant. Topical corticosteroids 
are preferred where an inflammatory pathogenesis is suspected. 
Azelastine nasal spray is an antihistamine and mast cell stabiliser and 
has been proven to be more effective than a placebo for patients with 
rhinorrhoea and/or a PND.6 In a few patients who fail medical therapy and 
have severe nasal blockage secondary to inferior turbinate hypertrophy, 
surgery is an option. The inferior turbinates play a very important role in 
humidification, filtration, heating and respiration, and turbinate surgery 
can be harmful and cause atrophic rhinitis. Only conservative trimming 
with preservation of mucosa should therefore be performed to improve 
the nasal airway and to allow for optimal administration of topical 
corticosteroids. 
3. Does the patient suffer from an infective rhinitis/rhinosinusitis?
The term rhinosinusitis is preferred rather than rhinitis, since the 
inflammation involves the mucosa of the nasal cavity and the paranasal 
sinuses. Rhinosinusitis can be classified as follows:7
•	 Acute (ARS): seven days to ≤ four weeks
•	 Sub-acute: four to twelve weeks
•	 Recurrent acute: ≥ four episodes of ARS a year
•	 Chronic (CRS): ≥ 12 weeks
•	 Acute exacerbation of chronic: Sudden worsening of CRS with 
return to baseline thereafter
The diagnosis of acute bacterial rhinosinusitis (ABRS) is based on 
symptoms/signs and can be made by a general practitioner without the 
need for nasal endoscopy or imaging studies. For ABRS to be diagnosed, 
two major factors or one major and two minor factors need to be present 
(Table III). 
These symptoms are useful in ABRS but become more difficult to apply in 
CRS because of the variety of associated conditions in CRS. Rhinosinusitis 
is a multifactorial disease and there are many different causes for 
sinus ostia obstruction with resultant inflammation of the paranasal 
sinus mucosa. Patients with recurrent ABRS or CRS not responding to 
therapy should be referred to a specialist for further investigations. Viral 
rhinosinusitis is usually self-limiting, but a combination of factors may 
lead to a chronic situation developing: anatomical variants occluding the 
natural drainage pathway of the sinuses; permanent damage to the cilia 
responsible for mucociliary clearance either by medication, pollutants 
or infections; or the presence of other co-morbidities. ABRS usually 
follows on an acute viral upper respiratory tract infection. Mucosal 
swelling leads to obstruction of the sinus ostia (especially in predisposed 
individuals), resulting in a reduction in oxygen tension in the sinuses 
with a reduction in mucociliary transport and transudation of fluid into 
the paranasal sinuses. Mucostasis leads to bacterial colonisation and a 






Sodium cromoglycate (nasal 
spray not available in SA)
+ + + / - -
Oral antihistamines +++ ++ + / - -
Ipratropium bromide - +++ - -
Topical decongestants - - +++ -
Topical corticosteroids +++ +++ ++ +
Oral corticosteroids +++ +++ +++ ++
Antileukotrienes - ++ + + / -
Table III: Rhinosinusitis symptoms/signs (two major or one major and two 
minor factors required for diagnosis)
Major symptoms Minor symptoms
1. Facial pain/pressure 1. Headache
2. Facial congestion/fullness 2. Fever (non-acute)
3. Nasal obstruction/blockage 3. Halitosis
4. Nasal discharge/purulence/discoloured PND 4. Fatigue
5. Hyposmia/anosmia 5. Dental pain
6. Purulence on nasal examination 6. Cough
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chronic situation can develop if ciliary action is not improved or the ostia 
remain obstructed. 
When patients complain of a PND it is therefore important to diagnose 
rhinosinusitis correctly and to improve the nasal-sinus environment as 
quickly as possible. Purulent nasal secretions on anterior rhinoscopy or 
the presence of a PND in the oropharynx strongly support the diagnosis of 
rhinosinusitis. The diagnosis of ABRS should be made on clinical grounds 
and criteria only. Plain radiographs are not cost-effective, have poor 
specificity and sensitivity and have no role in the acute situation, except 
possibly in children where maxillary sinus washouts are considered 
after optimal medical treatment.8 If the symptom complex suggests 
the diagnosis, empiric therapy should be commenced according to 
the most likely organism responsible. Streptococcus pneumoniae and 
Haemophilus influenzae are the most common organisms responsible 
for ABRS. Antibiotic therapy is usually only indicated seven to ten days 
after the onset of symptoms. Studies have however shown no major 
difference in cure rates between patients given antibiotics versus a 
placebo. Antibiotics do however reduce the symptom severity and reduce 
the recovery time. 
CRS is a multifactorial disease and diagnosis and treatment can be 
challenging. Anterior rhinoscopy is often normal, especially in a patient 
who has had no previous sinus surgery. Patients often complain of a PND, 
but this is infrequently seen. If CRS is suspected, nasal endoscopy is 
useful to determine the presence of anatomical abnormalities such as a 
concha bullosa (aerated middle turbinate), deviated nasal septum, nasal 
polyps or lesions/tumours requiring further investigation. Computerised 
tomography (CT) scans are helpful to determine response to treatment 
and to decide whether surgical intervention is required after optimal 
medical treatment, and should only be performed after six to eight weeks 
after the commencement of such treatment. 
The treatment of CRS with polyposis also differs from that of CRS 
without polyposis. If polyps are visible, empiric therapy consisting 
of topical and systemic corticosteroids (if no contra-indications exist) 
with a macrolide antibiotic can be commenced. Macrolide antibiotics 
have an important immunomodulatory role by down-regulating pro-
inflammatory mechanisms and are the preferred antibiotics in patients 
with CRS.9 Certain conditions are closely associated with nasal 
polyposis and patients should be assessed for asthma, cystic fibrosis 
(especially in children) and aspirin sensitivity. CRS is an inflammatory 
disease with multiple potential associated or aetiologic factors and a 
specific organism cannot always be identified. In patients with potential 
pathogenic bacteria, Staphylococcus species are the most common with 
Enterobacteriaceae, anaerobes, Gram-negative bacteria and fungi also 
showing a high prevalence. 
Conclusion
A careful history should be obtained in patients complaining of a PND 
or ‘sinusitis’. Allergic rhinitis should first be treated, causes of non-
allergic rhinitis looked for and irritants avoided, rhinosinusitis diagnosed 
and correctly classified and managed. If a PND persists, especially 
with associated nasal symptoms, patients should be referred to an 
ear, nose and throat (ENT) surgeon for endoscopy. CT scans are only 
performed to assess the response to treatment, to exclude the presence 
of complications in ABRS and to plan endoscopic sinus surgery. 
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